In ₹ Crore except Per Share Latest Annual	AGARWALEYE FY26	AKUMS FY26	ADVENZYMES FY26	ALIVUS FY24	Peer Average
Valuation — at last close
P/E	116.08×	44.45×	◆ 17.52×	—	30.99× +275%
P/B	7.64×	3.42×	◆ 1.81×	—	2.62× +192%
EV/EBITDA	27.13×	18.69×	◆ 10.16×	—	14.43× +88%
Market Cap	₹15,482 Cr	₹11,346 Cr	₹2,956 Cr	—	₹7,151 Cr +116%
Growth
Revenue CAGR 3Y	—	—	11.32%	—	11.32%
Revenue CAGR 5Y	—	—	8.24%	—	8.24%
Net Income CAGR 3Y	—	—	18.68%	—	18.68%
Revenue YoY (latest Q)	◆ 25.97%	13.93%	2.08%	—	8.00% +224%
Net Income YoY (latest Q)	44.56%	◆ 56.11%	-4.58%	—	25.77% +73%
Profitability
EBITDA Margin	27.38%	11.98%	◆ 30.72%	29.53%	24.08% +14%
Net Income Margin	8.08%	5.88%	◆ 23.28%	20.62%	16.59% -51%
Return on Common Equity	6.84%	8.02%	11.05%	◆ 21.07%	13.38% -49%
Return on Capital Employed	8.79%	9.71%	11.61%	◆ 26.94%	16.09% -45%
Return on Assets	4.42%	5.36%	10.03%	◆ 16.96%	10.78% -59%
Credit & Quality
Total Debt/Equity	0.07×	0.02×	◆ 0.01×	—	0.01× +367%
Interest Coverage	3.24×	3.91×	71.91×	◆ 401.55×	159.12× -98%
Scale — latest FY
Revenue / Total Income	₹2,080 Cr	₹4,359 Cr	₹746 Cr	₹2,283 Cr	₹2,463 Cr -16%
Net Income	₹168 Cr	₹256 Cr	₹174 Cr	₹471 Cr	₹300 Cr -44%
Total Assets	₹3,942 Cr	₹5,447 Cr	₹1,839 Cr	₹2,850 Cr	₹3,379 Cr +17%
EPS	₹4.21	₹16.67	₹15.08	—	₹15.88 -73%
Book Value per Share	₹63.93	₹216.41	₹145.81	—	₹181.11 -65%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.